Crypto investment firm 21Shares has officially filed with the U.S. Securities and Exchange Commission SEC for a spot ETF targeting Injective INJ. The filing represents a key step in expanding institutional access to DeFi-focused digital assets.
The proposed ETF will hold physical INJ tokens in cold storage, mirroring the structure of approved spot ETFs for Bitcoin and Ethereum. According to 21Shares official filing, the fund is designed to give investors direct exposure to Injective, simplifying participation in the blockchains growing ecosystem.
The news was shared via Injectives official X account, boosting token visibility and reinforcing market sentiment. Observers note that the ETF follows a similar filing by Canary Capital in July, marking a broader institutional push into Injective and Layer-1 blockchain infrastructure.
